molecules-logo

Journal Browser

Journal Browser

Editorial Board for section 'Bioactive Lipids'

Please see the section webpage for more information on this section.

Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.

Members

*
Website
Section Editor-in-Chief
1. Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
2. European Center for Brain Research, Santa Lucia Foundation IRCCS, Rome, Italy
Interests: arachidonate cascade; bioactive lipids; biomarkers; cell membranes; endocannabinoids; resolvins; signal transduction
* Section: Bioactive Lipids
Special Issues, Collections and Topics in MDPI journals

Website
Section Associate Editor
Instituto de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Universidad Complutense de Madrid, Madrid, Spain
Interests: endocannabinoids; neuroprotective compounds; inflammation; lipids mediators; biomarkers; kinase inhibitors
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Institute of Molecular Psychiatry, Medical Faculty, University of Bonn, Bonn, Germany
Interests: cannabinoids; opioids; addiction; aging; anxiety; depression

Website
Section Board Member
Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological University, Vernadskogo Pr. 86, 119571 Moscow, Russia
Interests: chemistry of polyunsaturated fatty acids and oxylipins; lipid peroxidation; lipoxygenases; protein-protein interactions; lipoxygenase inhibitors; allosterism; structure-activi
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Department of Experimental Neurobiology (Work Group: Psychedelics, Neuroactive Drugs and Addiction), National Institute of Mental Health, Klecany, Czech Republic
Interests: new psychoactive substances; acute behavioural effects in animal model; radioligand binding assays; serotonin and dopamine transporter; addiction; depression; anxiety
Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, Naples, Italy
Interests: drug design; drug discovery; computational chemistry; medicinal chemistry; pharmacologically active molecules; receptor modulation and binding

Website
Section Board Member
Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
Interests: endocannabinoid system; intracellular signalling; biomarkers; neuroprotection; learning and memory; transgenic models

Website
Section Board Member
Faculty of Veterinary Medicine, University of Teramo, Teramo, Italy
Interests: biochemistry; endocannabinoid system; neuroscience; neurodegeneration
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Faculty of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, Via Balzarini, Teramo, Italy
Interests: molecular mechanisms; epigenetics; gene expression; DNA methylation; biomarkers; endocannabinoids
Special Issues, Collections and Topics in MDPI journals
Department of Neurochemistry, Maj Institute of Pharmacology of the Polish Academy of Sciences, Krakow, Poland
Interests: bioactive lipids; biomarkers; endocannabinoid; cannabinoid receptors; pain; chronic pain; osteoarthritis
Prof. Dr. Natsuo Ueda
Website
Section Board Member
Department of Biochemistry, Kagawa University School of Medicine, Kagawa, Japan
Interests: lipid biochemistry; enzymology

Website
Section Board Member
1. Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel
2. Multidisciplinary Center for Cannabinoid Research, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel
Interests: endocannabinoids; metabolic syndrome; obesity; fatty liver disease; chronic kidney disease; acute kidney injury; drug discovery and development
Back to TopTop